Monument Capital Management cut its stake in Synopsys, Inc. (NASDAQ:SNPS) by 3.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,764 shares of the semiconductor company’s stock after selling 773 shares during the quarter. Synopsys accounts for about 1.6% of Monument Capital Management’s portfolio, making the stock its 9th biggest position. Monument Capital Management’s holdings in Synopsys were worth $2,987,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently modified their holdings of SNPS. Amundi Pioneer Asset Management Inc. raised its stake in shares of Synopsys by 11.2% in the first quarter. Amundi Pioneer Asset Management Inc. now owns 732,929 shares of the semiconductor company’s stock worth $84,398,000 after purchasing an additional 73,632 shares during the last quarter. FMR LLC increased its position in shares of Synopsys by 1.1% during the first quarter. FMR LLC now owns 257,171 shares of the semiconductor company’s stock valued at $29,613,000 after acquiring an additional 2,914 shares during the last quarter. Dorsey Wright & Associates increased its position in shares of Synopsys by 0.6% during the second quarter. Dorsey Wright & Associates now owns 42,193 shares of the semiconductor company’s stock valued at $5,430,000 after acquiring an additional 232 shares during the last quarter. Davis Rea LTD. increased its position in shares of Synopsys by 10.3% during the second quarter. Davis Rea LTD. now owns 19,660 shares of the semiconductor company’s stock valued at $2,530,000 after acquiring an additional 1,830 shares during the last quarter. Finally, WINTON GROUP Ltd increased its position in shares of Synopsys by 3,944.7% during the second quarter. WINTON GROUP Ltd now owns 249,035 shares of the semiconductor company’s stock valued at $32,048,000 after acquiring an additional 242,878 shares during the last quarter. 89.35% of the stock is owned by hedge funds and other institutional investors.

In other news, CEO Chi-Foon Chan sold 4,578 shares of the firm’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $137.14, for a total value of $627,826.92. Following the completion of the transaction, the chief executive officer now directly owns 199,539 shares of the company’s stock, valued at $27,364,778.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, General Counsel John F. Runkel, Jr. sold 10,000 shares of the firm’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $137.47, for a total value of $1,374,700.00. Following the completion of the transaction, the general counsel now directly owns 16,848 shares of the company’s stock, valued at $2,316,094.56. The disclosure for this sale can be found here. Over the last three months, insiders have sold 22,589 shares of company stock valued at $3,158,514. 1.84% of the stock is owned by corporate insiders.

NASDAQ SNPS traded up $1.74 on Monday, hitting $136.69. 717,829 shares of the stock traded hands, compared to its average volume of 1,107,076. The business’s fifty day moving average is $138.17 and its two-hundred day moving average is $128.72. Synopsys, Inc. has a 12 month low of $79.14 and a 12 month high of $146.66. The firm has a market capitalization of $20.28 billion, a price-to-earnings ratio of 48.47, a PEG ratio of 3.62 and a beta of 1.21. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.90 and a current ratio of 0.99.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Wednesday, August 21st. The semiconductor company reported $0.65 earnings per share for the quarter, beating the consensus estimate of $0.62 by $0.03. Synopsys had a return on equity of 16.56% and a net margin of 18.94%. The business had revenue of $853.00 million during the quarter, compared to analyst estimates of $831.03 million. During the same period in the prior year, the company earned $0.95 earnings per share. Synopsys’s revenue was up 9.5% compared to the same quarter last year. Analysts expect that Synopsys, Inc. will post 3.15 EPS for the current fiscal year.

SNPS has been the subject of a number of research analyst reports. Bank of America initiated coverage on Synopsys in a research report on Monday, September 23rd. They set a “buy” rating and a $171.00 price target for the company. BidaskClub downgraded Synopsys from a “buy” rating to a “hold” rating in a research report on Saturday. Wells Fargo & Co reaffirmed an “outperform” rating and set a $160.00 price target (up from $150.00) on shares of Synopsys in a research report on Thursday, August 22nd. ValuEngine downgraded Synopsys from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, Needham & Company LLC set a $145.00 price target on Synopsys and gave the company a “buy” rating in a research report on Monday, September 30th. Four investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $145.64.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits (ICs). It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Article: Capital Gains

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.